These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 29922941
21. Levosimendan Versus Milrinone for Inotropic Support in Pediatric Cardiac Surgery: Results From a Randomized Trial. Thorlacius EM, Wåhlander H, Ojala T, Ylänen K, Keski-Nisula J, Synnergren M, Romlin BS, Ricksten SE, Castellheim A. J Cardiothorac Vasc Anesth; 2020 Aug; 34(8):2072-2080. PubMed ID: 32201198 [Abstract] [Full Text] [Related]
22. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children]. Prijić S, Rakić S, Nikolić L, Jovicić B, Stajević M, Vukomanović V, Kosutić J. Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317 [Abstract] [Full Text] [Related]
23. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene. Hillestad V, Kramer F, Golz S, Knorr A, Andersson KB, Christensen G. J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410 [Abstract] [Full Text] [Related]
24. Adenosine A2A and A2B Receptor Substantially Attenuate Ischemia/Reperfusion Injury in Septic rat Hearts. Busse H, Bitzinger D, Höcherl K, Seyfried T, Gruber M, Graf BM, Zausig YA. Cardiovasc Drugs Ther; 2016 Dec; 30(6):551-558. PubMed ID: 27757725 [Abstract] [Full Text] [Related]
26. Clinical efficacy of levosimendan vs milrinone in preventing low cardiac output syndrome following pediatric cardiac surgery. Jothinath K, Balakrishnan S, Raju V, Menon S, Osborn J. Ann Card Anaesth; 2021 Dec; 24(2):217-223. PubMed ID: 33884979 [Abstract] [Full Text] [Related]
27. The efficacy of levosimendan and dobutamine on reducing peripheral blood interleukin-6 levels and improving cardiac function in patients with septic cardiomyopathy: a comparative study. Sun T, Sun QL, Liu Y, Zhang YY, Sheng P, Cui N, Zhang N, Wang SH, Su D. J Physiol Pharmacol; 2024 Aug; 75(4):. PubMed ID: 39415525 [Abstract] [Full Text] [Related]
30. Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension. Nag P, Chowdhury SR, Behera SK, Das M, Narayan P. J Cardiothorac Vasc Anesth; 2023 Jun; 37(6):972-979. PubMed ID: 36906394 [Abstract] [Full Text] [Related]
32. Cardioprotective effects of irbesartan in polymicrobial sepsis : The role of the p38MAPK/NF-κB signaling pathway. Yousif NG, Hadi NR, Al-Amran F, Zigam QA. Herz; 2018 Mar; 43(2):140-145. PubMed ID: 28144715 [Abstract] [Full Text] [Related]
33. Levosimendan up-regulates transforming growth factor-beta and smad signaling in the aorta in the early stage of sepsis. Erbüyün K, Tok D, Vatansever S, Ok G, Türköz E, Aydede H, Erhan Y, Tekin I. Ulus Travma Acil Cerrahi Derg; 2010 Jul; 16(4):293-9. PubMed ID: 20849043 [Abstract] [Full Text] [Related]
38. Sulfur dioxide attenuates sepsis-induced cardiac dysfunction via inhibition of NLRP3 inflammasome activation in rats. Yang L, Zhang H, Chen P. Nitric Oxide; 2018 Dec 01; 81():11-20. PubMed ID: 30273666 [Abstract] [Full Text] [Related]
39. Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials. Chang W, Xie JF, Xu JY, Yang Y. BMJ Open; 2018 Mar 30; 8(3):e019338. PubMed ID: 29602841 [Abstract] [Full Text] [Related]
40. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study. Lechner E, Hofer A, Leitner-Peneder G, Freynschlag R, Mair R, Weinzettel R, Rehak P, Gombotz H. Pediatr Crit Care Med; 2012 Sep 30; 13(5):542-8. PubMed ID: 22622649 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]